These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8135459)

  • 1. Prednisone in managing rheumatoid arthritis.
    Romano TJ
    Ann Intern Med; 1994 Apr; 120(8):693-4. PubMed ID: 8135459
    [No Abstract]   [Full Text] [Related]  

  • 2. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy.
    Sambrook P; Nguyen T
    Br J Rheumatol; 1992 Aug; 31(8):573-4. PubMed ID: 1643463
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteoporosis and cutaneous atrophy during the treatment of rheumatoid polyarthritis with cortisone derivatives].
    Ryckewaert A; Kuntz D; de Beyre N; Panneguin P; de Séze S
    Rev Rhum Mal Osteoartic; 1971; 38(8):489-95. PubMed ID: 5159054
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone dynamics of rheumatoid arthritis treated with adrenal corticosteroids.
    Duncan H
    Arthritis Rheum; 1967 Jun; 10(3):216-27. PubMed ID: 6028074
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries for patients. Prednisone for rheumatoid arthritis.
    Ann Intern Med; 2002 Jan; 136(1):I-26. PubMed ID: 11777372
    [No Abstract]   [Full Text] [Related]  

  • 6. Osteoporosis in rheumatoid arthritis and corticosteroid induced osteoporosis.
    Duncan H
    Orthop Clin North Am; 1972 Nov; 3(3):571-83. PubMed ID: 4565583
    [No Abstract]   [Full Text] [Related]  

  • 7. Low-dose prednisone therapy for patients with early active rheumatoid arthritis: clinical efficacy, disease-modifying properties, and side effects: a randomized, double-blind, placebo-controlled clinical trial.
    van Everdingen AA; Jacobs JW; Siewertsz Van Reesema DR; Bijlsma JW
    Ann Intern Med; 2002 Jan; 136(1):1-12. PubMed ID: 11777359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and management of glucocorticoid-induced osteoporosis.
    Lane NE; Mroczkowski PJ; Hochberg MC
    Bull Rheum Dis; 1995 Aug; 44(5):1-4. PubMed ID: 7550788
    [No Abstract]   [Full Text] [Related]  

  • 9. Osteoporosis management in patients with rheumatoid arthritis: Evidence for improvement.
    Solomon DH; Katz JN; Cabral D; Patrick AR; Bukowski JF; Coblyn JS
    Arthritis Rheum; 2006 Dec; 55(6):873-7. PubMed ID: 17139663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality assurance study of the use of preventative therapies in glucocorticoid-induced osteoporosis in early inflammatory arthritis: results from the CATCH cohort.
    McKeown E; Bykerk VP; De Leon F; Bonner A; Thorne C; Hitchon CA; Boire G; Haraoui B; Ferland DS; Keystone EC; Pope JE;
    Rheumatology (Oxford); 2012 Sep; 51(9):1662-9. PubMed ID: 22539481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are glucocorticoids harmful to bone in early rheumatoid arthritis?
    Lems WF
    Ann N Y Acad Sci; 2014 May; 1318():50-4. PubMed ID: 24739059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Iatrogenic osteoporsis: six case reports].
    Zheng LM; Wang JZ
    Zhonghua Nei Ke Za Zhi; 1994 Oct; 33(10):658-60. PubMed ID: 7712909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice.
    Solomon DH; Katz JN; Jacobs JP; La Tourette AM; Coblyn J
    Arthritis Rheum; 2002 Dec; 46(12):3136-42. PubMed ID: 12483716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-induced arthropathy and necrosis of the femoral head.
    Solomon L
    J Bone Joint Surg Br; 1973 May; 55(2):246-61. PubMed ID: 4145274
    [No Abstract]   [Full Text] [Related]  

  • 15. Limited bone loss due to corticosteroids; a systematic review of prospective studies in rheumatoid arthritis and other diseases.
    Verhoeven AC; Boers M
    J Rheumatol; 1997 Aug; 24(8):1495-503. PubMed ID: 9263141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis.
    Krasselt M; Baerwald C
    Drug Des Devel Ther; 2016; 10():1047-58. PubMed ID: 27022244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice patterns in patients at risk for glucocorticoid-induced osteoporosis.
    Feldstein AC; Elmer PJ; Nichols GA; Herson M
    Osteoporos Int; 2005 Dec; 16(12):2168-74. PubMed ID: 16142501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rheumatoid arthritis and prednisone-induced scurvy.
    Bartholomew C
    Postgrad Med J; 1972 Apr; 48(559):243-5. PubMed ID: 4538611
    [No Abstract]   [Full Text] [Related]  

  • 19. [Role of corticotherapy in vertebral osteoporosis in rheumatoid arthritis].
    Vignon G; Bied JC
    Rev Rhum Mal Osteoartic; 1968 Mar; 35(3):87-9. PubMed ID: 5672052
    [No Abstract]   [Full Text] [Related]  

  • 20. Cryptococcal meningoencephalitis in a patient with rheumatoid arthritis treated with methotrexate and prednisone.
    Trillos RF; Fernández-Ávila DG; Díaz MC; Gutiérrez JM
    Reumatol Clin; 2014; 10(5):346-7. PubMed ID: 24746915
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.